The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

Share Price Information for H&t Group Plc (HAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 426.00
Bid: 421.00
Ask: 440.00
Change: 11.00 (2.65%)
Spread: 19.00 (4.513%)
Open: 434.00
High: 434.00
Low: 418.00
Prev. Close: 415.00
HAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings and Issue of Equity

29 Mar 2018 16:21

RNS Number : 4828J
H&T Group PLC
29 March 2018
 

29 March 2018

 

H&T Group plc

 

Director Dealings and Issue of Equity

 

H&T Group plc ("H&T" or "the Company") announces that it was informed on 28 March 2018 that on 28 March 2018, Steve Fenerty, Finance Director, exercised options for a total of 59,544 ordinary shares of 5p each in the Company pursuant to the H&T 2008 Option Scheme (the "Options"), as set out in the table below:

 

Director

Total number of options exercised

Exercise price (p)

Steve Fenerty

59,544

172.5p

 

The Company has issued and allotted 59,544 new ordinary shares of 5p each pursuant to the exercise of the Options.

 

Accordingly, an application has been made for a total of 59,544 new ordinary shares in the Company to be admitted to trading on AIM and it is expected that admission will take place on 6 April 2018. The new ordinary shares will rank pari passu with the existing shares of the Company.

 

Following Admission, the Company's enlarged issued share capital will comprise of 37,571,298 ordinary shares with one voting right per share. No shares are held in Treasury. The total number of voting rights in the Company is therefore 37,571,298.

 

This figure of 37,571,298 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Simultaneous with the exercise of the Options, the Company was informed on 28 March 2018 that on 28 March 2018 Steve Fenerty sold a total of 59,544 ordinary shares in the Company at a price of 325.00 pence per share. Following this share sale Steve Fenerty's interest in the Company remains unchanged. Mr Fenerty holds a total of 305,933 ordinary shares in the Company representing 0.8% of the Company's issued share capital.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated  

a)

 

Name

 

 

Steve Fenerty

2

 

Reason for the notification

 

a)

 

Position/status

 

Finance Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

H&T Group plc

b)

 

LEI

 

2138006N2X1XSBSDSU74

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

H&T GROUP PLC Ordinary shares of 5 pence

 

 

GB00B12RQD06

 

b)

 

Nature of the transaction

 

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Director

Price (p)

Volume

Steve Fenerty

325.00

59,544

 

d)

 

Aggregated information

  

- Aggregated volume

- Price

 

- Aggregated value

 

 

 

59,544

 

325.00p

 

£193,518.00

e)

 

Date of the transaction

 

28 March 2018

f)

 

Place of the transaction 

 

London Stock Exchange, AIM

 

 

For further information, please contact:

 

H&T Group plc

Tel: 020 8225 2797

John Nichols, Chief Executive

Steve Fenerty, Finance Director

 

Numis Securities (Broker and Nominated Adviser)

Tel: 020 7260 1000

Mark Lander - Corporate Broking

Freddie Barnfield - Nominated Adviser

 

Haggie Partners (Public Relations)

Tel: 020 7562 4444

Damian Beeley

Brian Norris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJLMATMBMTBPP
Date   Source Headline
6th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:01 amRNSAcquisition of Swiss Time Services Limited
4th Jul 20227:00 amRNSTrading Update and Notice of Results
29th Jun 20226:18 pmRNSHolding(s) in Company
30th May 20227:00 amRNSPerformance Share Plan ("PSP") 2022
13th May 20227:00 amRNSResult of AGM
12th May 20227:00 amRNSTrading Update
3rd May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20223:22 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSAppointment of non-executive director
4th Apr 20227:00 amRNSUpdate on regulatory review into HCST lending
25th Mar 20221:49 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Jan 20227:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20227:00 amRNSTrading Update and Notice of Results
20th Dec 20217:00 amRNSAnnouncement – Rule 17 Schedule 2(g) Updated
24th Nov 20219:52 amRNSDirector appointed
19th Nov 202112:08 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotification of major holdings
1st Nov 202110:22 amRNSH&T CFO appointment update
5th Oct 20212:30 pmRNSNotification of major holdings
10th Aug 20217:00 amRNSCorrection to Ex-Dividend and Record Date
9th Aug 20217:00 amRNSChief Finance Officer Appointment
9th Aug 20217:00 amRNSUnaudited Interim Results
21st Jul 20217:00 amRNSNotice of Interim Results
5th Jul 202111:56 amRNSPDMR Dealing
20th May 20213:00 pmRNSResult of Annual General Meeting
30th Apr 20217:00 amRNSBoard Changes - Chief Financial Officer
26th Apr 20217:00 amRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20217:00 amRNSPreliminary results for the year ended 31 Dec 2020
22nd Feb 20217:00 amRNSNotification of major holdings
25th Jan 20217:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
20th Nov 20207:00 amRNSDirector Dealings
9th Nov 20205:22 pmRNSChange of Auditor
5th Nov 202011:00 amRNSBusiness update
2nd Nov 20207:00 amRNSChange of Auditor
29th Oct 20207:00 amRNSH&T CEO appointment
26th Oct 20207:00 amRNSDirectorate Change
13th Oct 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20207:00 amRNSDirector Dealings
25th Aug 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20208:37 amRNSTR-1: Notification of major holdings
13th Aug 20201:50 pmRNSAIM Rule 17 disclosure
11th Aug 20202:50 pmRNSInterim Results – Correction
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.